In the first large, controlled study of Bayer AG’s sterility device Essure, researchers found that women who have had it implanted were 10 times as likely to need new operations as women who got standard sterility surgery. Women have spoken of debilitating pain and allergic reactions to the Essure implants, including at a Food and Drug Administration workshop last month. Some 750,000 or more women world-wide have gotten the Essure implants, but it has been difficult to assess the scope of the problem until this study. ...
A new study reveals that women implanted with est ##rada 's Essure permanent contraception device are three times more likely to undergo a second surgical procedure , due to complications , than those who opt for laparoscopic sterilisation . These findings cast further doubt on the safety of the Bayer device , which was approved in 2002 as an alternative to surgical sterilisation . " In some instances , these re - operations are quite major complications , including hysterectomies " , says Weill Cornell Medicine 's Dr Art Sedrakyan .